DENMAB 60MG INJECTION

Denmab 60mg Injection is made up of an active substance called Denosumab. It is a drug for treating osteoporosis that is defined by weaker bones. It can also be prescribed to reduce the risk of bone-related complications in patients suffering from certain types of cancers, including bone metastases and myeloma. Denmab 60mg Injection functions by preventing the activity of a protein known as RANK, the ligand involved in the destruction of the bone. Research has demonstrated that it can significantly increase bone density while reducing the risk of fractures in postmenopausal women with osteoporosis, as well as those suffering from cancer-related loss of bone. Monitoring renal function closely is recommended for patients with moderate renal function impairment.
Denmab 60mg Injection shouldn’t be used by patients suffering from known allergies or hypersensitivity in response to the components. Proper vitamin D and calcium intake are essential to maintain the treatment. It is not a medical device approved for use by children and adolescents. The safety and effectiveness of the medication in children have not been proven. Therefore, its use is not recommended for people under 18. This medication should be taken with caution in people who have hypoparathyroidism characterized by low levels of parathyroid hormone.